Strategies to enhance risk communication about medicines in Malaysia: a Delphi study among multinational experts.

ABSTRACT:

Background

Effective risk communication about medicines is crucial to the success of all pharmacovigilance activities but remains a worldwide challenge. Risk communication has been conducted in Malaysia for decades, yet awareness on the communication methods remains low among healthcare professionals. While international guidelines are available, clear guidance on effectively communicating the risks of medicines in specific countries is scarce. This study aimed to establish a consensus on the priority strategies for enhancing risk communication about medicines by regulators.

Methods

We conducted a two-round modified Delphi survey among local and international communication experts, and also recipients of medicines risk communication in Malaysia. We developed a list of 37 str

SUBMITTER: Panickar R 

PROVIDER: S-EPMC11373486 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature